Peptídeos
Os peptídeos são cadeias curtas de aminoácidos ligados por ligações peptídicas, desempenhando papéis importantes como moléculas biológicas em processos celulares. Eles funcionam como hormônios, neurotransmissores e moléculas de sinalização, sendo amplamente utilizados em aplicações terapêuticas e diagnósticas. Os peptídeos também são cruciais na pesquisa para estudar interações proteicas, atividades enzimáticas e vias de sinalização celular. Na CymitQuimica, oferecemos uma ampla seleção de peptídeos de alta qualidade para apoiar suas necessidades de pesquisa e desenvolvimento em biotecnologia e farmacêutica.
Subcategorias de "Peptídeos"
Foram encontrados 29793 produtos de "Peptídeos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
KLK10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KLK10 antibody, catalog no. 70R-5662
Pureza:Min. 95%ETFB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ETFB antibody, catalog no. 70R-2458Pureza:Min. 95%KLHDC4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KLHDC4 antibody, catalog no. 70R-5482Pureza:Min. 95%Vwa5a Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Vwa5a antibody, catalog no. 70R-9304Pureza:Min. 95%Perilipin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PLIN antibody, catalog no. 70R-1297Pureza:Min. 95%TPD52 Blocking Peptide
Please enquire for more information about TPD52 Blocking Peptide including the price, delivery time and more detailed product information at the technical inquiry form on this pagePureza:Min. 95%CHAC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CHAC1 antibody, catalog no. 70R-3936Pureza:Min. 95%EPRS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EPRS antibody, catalog no. 70R-3501Pureza:Min. 95%RFPL3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RFPL3 antibody, catalog no. 70R-1162Pureza:Min. 95%Claudin 5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLDN5 antibody, catalog no. 70R-6137Pureza:Min. 95%ApoBEC3F Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of APOBEC3F antibody, catalog no. 70R-4925Pureza:Min. 95%ISG20 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ISG20 antibody, catalog no. 70R-4698Pureza:Min. 95%NAT12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NAT12 antibody, catalog no. 70R-2955
Pureza:Min. 95%P2RX1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of P2RX1 antibody, catalog no. 70R-1546Pureza:Min. 95%PARP2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PARP2 antibody, catalog no. 70R-2437Pureza:Min. 95%Ub4ix
The ability to modify ubiquitin chains would be a useful research tool for understanding ubiquitin signalling in health and disease. The initial step in ubiquitin signalling is attachment of a ubiquitin molecule to a lysine residue, further ubiquitins can then be added to the initial monomer creating a chain. The chain length and location can affect the fate of the protein. The most well studied are lysine 48 (K48) linked ubiquitin chains. K48 polyubiquitin chains are recognised by deubiquitinating enzymes (DUBS) and targeted for proteasomal degradation. Macrocyclic peptides are being explored as ubiquitin ligands to better understand ubiquitin signalling.Ub4ix is a macrocyclic peptide that selectively binds to lysine48-linked ubiquitin dimer (K48-Ub2), with much higher affinity than linear counterparts. Importantly, binding of ub4ix to K48-Ub2 prevents recognition by DUBS thus inhibiting protein targeting for proteosomal degradation. This has been shown to promote apoptosis in cancer cells. Therefore, molecules like ub4ix could be a valuable tool in understanding ubiquitin signalling as well as lead to future disease treatments. Potentially, the ubiquitin system in could be a target for cancer therapy to alter the polyubiquitin recognition by interacting proteins, further work with ubi4x could provide vital steps along this path.Peso molecular:1,766.7 g/molFLJ12529 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ12529 antibody, catalog no. 70R-1303Pureza:Min. 95%ACO2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACO2 antibody, catalog no. 70R-2445Pureza:Min. 95%TMEM149 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM149 antibody, catalog no. 70R-7261Pureza:Min. 95%PRPS2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PRPS2 antibody, catalog no. 70R-3917Pureza:Min. 95%Abcc2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Abcc2 antibody, catalog no. 70R-8565Pureza:Min. 95%CFD Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CFD antibody, catalog no. 70R-10007Pureza:Min. 95%KLC3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KLC3 antibody, catalog no. 70R-2517Pureza:Min. 95%ZNF30 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF30 antibody, catalog no. 70R-8170Pureza:Min. 95%ZFP91 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZFP91 antibody, catalog no. 20R-1105
Pureza:Min. 95%Cyyr1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Cyyr1 antibody, catalog no. 70R-8636
Pureza:Min. 95%OGT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OGT antibody, catalog no. 70R-2046Pureza:Min. 95%SLC26A4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC26A4 antibody, catalog no. 70R-7041Pureza:Min. 95%Dag1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Dag1 antibody, catalog no. 70R-8652
Pureza:Min. 95%VPS8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of VPS8 antibody, catalog no. 70R-3086Pureza:Min. 95%TRIM45 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TRIM45 antibody, catalog no. 70R-2222Pureza:Min. 95%HSZFP36 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HSZFP36 antibody, catalog no. 70R-7957Pureza:Min. 95%SITPEC Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SITPEC antibody, catalog no. 20R-1136Pureza:Min. 95%GPT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPT antibody, catalog no. 70R-1194Pureza:Min. 95%SLFN12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLFN12 antibody, catalog no. 70R-4360Pureza:Min. 95%PGM1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PGM1 antibody, catalog no. 70R-3469Pureza:Min. 95%DDX46 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DDX46 antibody, catalog no. 70R-4793Pureza:Min. 95%ABCF2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ABCF2 antibody, catalog no. 70R-5704Pureza:Min. 95%RBM9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RBM9 antibody, catalog no. 70R-1432Pureza:Min. 95%SSR1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SSR1 antibody, catalog no. 70R-6619Pureza:Min. 95%PIK3IP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PIK3IP1 antibody, catalog no. 70R-7448Pureza:Min. 95%ARPC3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARPC3 antibody, catalog no. 70R-3074Pureza:Min. 95%EPS8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EPS8 antibody, catalog no. 70R-3683Pureza:Min. 95%DPY19L4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DPY19L4 antibody, catalog no. 70R-7039Pureza:Min. 95%RASSF1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RASSF1 antibody, catalog no. 70R-9845Pureza:Min. 95%GAD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GAD1 antibody, catalog no. 70R-4463Pureza:Min. 95%GNAS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GNAS antibody, catalog no. 70R-1643Pureza:Min. 95%RBM18 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RBM18 antibody, catalog no. 70R-8492Pureza:Min. 95%INSIG1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of INSIG1 antibody, catalog no. 70R-6594
Pureza:Min. 95%FBXW11 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FBXW11 antibody, catalog no. 70R-2812Pureza:Min. 95%AFM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AFM antibody, catalog no. 70R-8008Pureza:Min. 95%MRPS2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MRPS2 antibody, catalog no. 70R-9443
Pureza:Min. 95%ETV3L Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ETV3L antibody, catalog no. 70R-8691Pureza:Min. 95%UBA6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBA6 antibody, catalog no. 70R-9758Pureza:Min. 95%CHST8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CHST8 antibody, catalog no. 70R-7126Pureza:Min. 95%U2AF2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of U2AF2 antibody, catalog no. 70R-1354Pureza:Min. 95%CKMM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CKM antibody, catalog no. 70R-1985Pureza:Min. 95%Chromogranin A (Human)-EIA Kit (1ea)
Chromogranin A (CgA) is a peptide hormone found in the human body that is released from the cells of the pancreas and stomach. The CgA-EIA Kit is a solid phase enzyme immunoassay that can be used to measure CgA levels in human serum or plasma. Antibodies against CgA are coated onto a microtiter plate, and samples are added to the wells. After incubation, any CgA in the sample binds to the antibodies on the plate. The bound CgA is then detected using specific antibodies conjugated with horseradish peroxidase. The color reaction is measured at 450 nm with a reference wavelength of 630 nm.Pureza:Min. 95%PPIH Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPIH antibody, catalog no. 70R-3821Pureza:Min. 95%Biotin Substance P
Substance P (SP) is a peptide that is highly conserved across the animal kingdom and is involved in a number of inflammatory and growth promoting processes. SP has a net positive charge at physiological pH, it is an amphiphilic peptide with positively charged residues at the N-terminus and hydrophobic residues at the C-terminus, this controls how it interacts with cell membranes. SP is stable in plasma (several hours) but has a short half-life in tissues (seconds/minutes).SP is encoded by the TAC1 gene and is a member of the tachykinin peptide hormone family. SP is expressed by many cell types including: neurons, astrocytes, microglia, epithelial cells, endothelial cells, immune cells such as T cells and macrophages- dendritic cells and eosinophils and some stem cells and progenitor cells. The huge variety of cell types expressing SP suggest it is involved in a wide variety of physiological and pathophysiological functions.SP mediates its functions by interacting with members of the neurokinin (NK) family of G protein-coupled receptors with high selectivity. Among these, SP binds to NK1R with the highest affinity, this receptor is expressed in a wide range of tissue types.Biotin (B7) has been added to the N-terminus.Peso molecular:1,572.8 g/molSSX2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX2 antibody, catalog no. 70R-8217Pureza:Min. 95%SPOCK3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SPOCK3 antibody, catalog no. 70R-6593Pureza:Min. 95%CCL7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CCL7 antibody, catalog no. 70R-7850
Pureza:Min. 95%GALNT4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GALNT4 antibody, catalog no. 70R-7245Pureza:Min. 95%Cpa3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Cpa3 antibody, catalog no. 70R-8523Pureza:Min. 95%USP3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of USP3 antibody, catalog no. 70R-8004Pureza:Min. 95%Histone H3-GG-[Cys(5-FAM)]-amide
Histone H3 peptide with a C-terminal GGC linker labelled with fluorescein.Peso molecular:2,825.4 g/molSEPN1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SEPN1 antibody, catalog no. 70R-8737Pureza:Min. 95%Magainin I
Magainins, also known as PGS (peptide glycine serine) are anti-microbial peptides originally isolated from the skin of the African clawed frog Xenopus laevis, they belong to a large family of amphibian amphipathic alpha-helical cationic anti-microbial peptides (CAMPs). Magainin I is active against a wide spectrum of pathogens including Gram-positive and Gram-negative bacteria, fungi and protozoa and has anti-viral properties against HIV and herpes simplex virus. Magainins also displays anti-tumour activities and are known to facilitate wound closure and to reduce inflammation.Magainin peptides act by first binding to and then causing eventual collapse of the membrane. Magainins, carry several positive charges, and interact best with membranes with a negative surface charge, such as bacteria or tumour cells. However they are non-toxic to healthy eukaryotic cells which are charge-neutral at their outer membrane. The physical mode of action of these peptides reduces the ability of target organisms to develop resistance to them, suggesting good therapeutic potential.Cor e Forma:PowderPeso molecular:2,321.3 g/molCRAMP (6-39)
Amino acids 6-39 of the cathelicidin-related anti-microbial peptide (CRAMP), the mouse homologue of the human LL-37 anti-microbial peptide.CRAMP possesses potent anti-bacterial activity against Gram-positive and Gram-negative bacterial strains with no haemolytic activity. As well as displaying direct anti-microbial activity, CRAMP also binds to lipopolysaccharide (LPS) to neutralise its activity.CRAMP is a cationic peptide, encoded for by the Camp gene and is highly expressed in bone marrow. Its expression is up-regulated by infectious and inflammatory signals and it is secreted by cells such as neutrophils-epithelial cells-and macrophages.Peso molecular:3,878.61 g/molA4GNT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of A4GNT antibody, catalog no. 70R-7408Pureza:Min. 95%DRAM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DRAM antibody, catalog no. 70R-9619Pureza:Min. 95%SLC22A23 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC22A23 antibody, catalog no. 70R-1742Pureza:Min. 95%[Cys(AF647)]-Jak2/3 substrate
This peptide is phosphorylated by Janus kinase 2 and 3 (JAK2 and JAK3) and is an ideal substrate for use in kinase assays. The JAK family of kinases is essential for the signalling of a host of immune modulators in tumour, stromal, and immune cells where they are highly expressed. JAK family proteins mediate the signalling of the interferon (IFN), IL-6, and IL-2 families of cytokines.JAK kinases are associated with cytokine receptors. Cytokine binding to these receptors results in activation of JAK kinases and receptor phosphorylation. Phosphorylated cytokine receptors recruit STAT proteins, which are then phosphorylated by the activated JAK kinases. Phosphorylated STAT proteins form homo- and hetero-dimers that translocate into the nucleus and function as transcription factors.This peptide contains an N-terminal Alexa Fluor 647 florescent dye. A cysteine residue has been added to the N-terminus for conjugation of the dye via the cysteine thiol moiety. AF647 is a bright, far-red-fluorescent dye with excitation between 594 nm and 633 nm, and is pH-insensitive over a wide molar range.FGFR1OP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FGFR1OP antibody, catalog no. 70R-4399Pureza:Min. 95%GRAMD3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GRAMD3 antibody, catalog no. 70R-8829Pureza:Min. 95%SLC16A6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC16A6 antibody, catalog no. 70R-6797
Pureza:Min. 95%CHRNA5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA5 antibody, catalog no. 70R-1529Pureza:Min. 95%CHRNA7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA7 antibody, catalog no. 70R-1540Pureza:Min. 95%CYP2B6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2B6 antibody, catalog no. 70R-5412Pureza:Min. 95%MAGEA10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA10 antibody, catalog no. 70R-3921
Pureza:Min. 95%UBE3B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBE3B antibody, catalog no. 70R-2574Pureza:Min. 95%UGCGL2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UGCGL2 antibody, catalog no. 70R-5282
Pureza:Min. 95%MKRN2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AMZ2 antibody, catalog no. 70R-9376Pureza:Min. 95%DHX8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DHX8 antibody, catalog no. 70R-4791Pureza:Min. 95%SUZ12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SUZ12 antibody, catalog no. 70R-8316Pureza:Min. 95%OR2M2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OR2M2 antibody, catalog no. 70R-9870Pureza:Min. 95%TSHR Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TSHR antibody, catalog no. 70R-1187Pureza:Min. 95%SPATA22 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SPATA22 antibody, catalog no. 70R-3027Pureza:Min. 95%C14ORF148 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C14orf148 antibody, catalog no. 70R-3453Pureza:Min. 95%P2RX2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of P2RX2 antibody, catalog no. 70R-5086Pureza:Min. 95%CARS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CARS antibody, catalog no. 70R-5006
Pureza:Min. 95%SAMD14 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SAMD14 antibody, catalog no. 70R-4194Pureza:Min. 95%LTA4H Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LTA4H antibody, catalog no. 70R-9264Pureza:Min. 95%RBM22 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RBM22 antibody, catalog no. 70R-4782Pureza:Min. 95%UCP3 Blocking Peptide
A synthetic UCP3 Blocking peptide for use as a blocking control in assays to test for specificity of UCP3 antibody, catalog no. 20R-UR003Pureza:Min. 95%XPO5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of XPO5 antibody, catalog no. 70R-8743Pureza:Min. 95%Cst6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Cst6 antibody, catalog no. 70R-9231Pureza:Min. 95%C21ORF87 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C21orf87 antibody, catalog no. 70R-1965Pureza:Min. 95%Thymopoietin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMPO antibody, catalog no. 70R-6298Pureza:Min. 95%
![Histone H3-GG-[Cys(5-FAM)]-amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FCRB1100317.webp&w=3840&q=75)
![[Cys(AF647)]-Jak2/3 substrate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FCRB1110313.webp&w=3840&q=75)
